High Fresh Gas Flow After Intubation

May 12, 2015 updated by: Erland Ostberg, Region Västmanland

High Fresh Gas Flow After Intubation - A Randomized Clinical Trial

Atelectasis is common during and after general anesthesia. Atelectasis develops early if preoxygenation with 100% oxygen is used and continuously used during induction until endotracheal intubation. The investigators hypothesize that a rapid anti-preoxygenation maneuver immediately after confirming a successful intubation, reduces the area of atelectasis as investigated by computed tomography compared to a standard procedure.

Study Overview

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Västmanland
      • Köping, Västmanland, Sweden, 731 30
        • Landstinget Västmanland

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy patients, American Society of Anesthesiology (ASA) I-II
  • Patients scheduled for orthopaedic day case surgery in general anaesthesia

Exclusion Criteria:

  • ASA class III or higher
  • Body Mass Index (BMI) 30 or higher
  • Arterial oxygen saturation (SpO2) <94% breathing air
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Ischemic heart disease
  • Haemoglobin <100g/L
  • Known or anticipated difficult airway and/or intubation
  • Active smokers and ex-smokers with a history of more than 6 pack years
  • Need for interscalene or supraclavicular regional anaesthesia with risk of phrenic nerve paralysis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control group, conventional ventilatory settings

Handling of the airway during induction and intubation is performed in a conventional manner.

Initial ventilatory settings are also done in a conventional manner.

Handling of the airway during induction and intubation is performed in a conventional manner.

Initial ventilatory settings are also done in a conventional manner. As soon as correct position of the endotracheal tube is confirmed, controlled ventilation is started with a tidal volume of 7 mL/kg ideal body weight, PEEP 6 or 8 cm H2O (8 if BMI >25) and a respiratory frequency of 10. The fresh gas flow is set to 1 Liter per minute with an oxygen mixture of 40%, aiming for an inspired FiO2 of 30-35%.

Unless the patient´s SpO2 falls below 90%, the FiO2 remains unchanged throughout the procedure.

Active Comparator: High fresh gas flow, high minute ventilation

Handling of the airway during induction and intubation is performed in a conventional manner.

Immediately after confirming a successful intubation the effect of preoxygenation is eliminated with an anti-preoxygenation maneuver.

Handling of the airway during induction and intubation is performed in a conventional manner.

Immediately after confirming a successful intubation, the effect of preoxygenation is eliminated with a fresh gas flow of 10 L/min of air, delivered with volume controlled ventilation consisting of tidal volumes of approximately 15 ml/kg ideal body weight, a positive expiratory pressure of 10 cm H20 and a respiratory frequency of 10. As soon as the end tidal O2 reaches 25%, the ventilator settings are adjusted to normal values (same as in the control group), i.e. tidal volume 7 mL/kg ideal body weight, PEEP 6 or 8 cm H2O (8 if BMI >25). The mixture of oxygen in the fresh gas is increased to 40% and the fresh gas flow is set to 1 Liter per minute, aiming for an inspired FiO2 of 30-35%.

Unless the patient´s SpO2 falls below 90%, the FiO2 remains unchanged throughout the procedure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Atelectasis
Time Frame: Within 1-2 hours, just before emergence from anesthesia
The area of atelectasis in the lungs is assessed by computed tomography (CT) 10 mm above the dome of the right diaphragm and expressed in cm2 and as % of the total lung area in the particular scan.
Within 1-2 hours, just before emergence from anesthesia

Secondary Outcome Measures

Outcome Measure
Time Frame
Arterial blood gases
Time Frame: Within 2-3 hours perioperatively
Within 2-3 hours perioperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Mats Enlund, MD, PhD, Landstinget i Värmland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2014

Primary Completion (Actual)

May 1, 2015

Study Completion (Actual)

May 1, 2015

Study Registration Dates

First Submitted

August 1, 2014

First Submitted That Met QC Criteria

August 12, 2014

First Posted (Estimate)

August 13, 2014

Study Record Updates

Last Update Posted (Estimate)

May 13, 2015

Last Update Submitted That Met QC Criteria

May 12, 2015

Last Verified

May 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • Dnr 2012/335

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Atelectasis

Clinical Trials on Control group, conventional ventilatory settings

Subscribe